ZYVERSA THERAPEUTICS, INC. Operating Lease, Liability, Current
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Operating Lease, Liability, Current of $8.66 thousand as of 2023-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2025-03-27
- 2023-12-31: Operating Lease, Liability, Current $8.66K.
- 2023-09-30: Operating Lease, Liability, Current $34.35K.
- 2023-06-30: Operating Lease, Liability, Current $59.63K.
- 2023-03-31: Operating Lease, Liability, Current $84.51K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2023-12-31 | $8.66K 10-K · filed 2025-03-27 |
| 2023-09-30 | $34.35K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $59.63K 10-Q · filed 2023-08-21 |
| 2023-03-31 | $84.51K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $108.76K 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |